Stockscreener 앱 받기
9.52
3.82%
0.35
시간 외 거래:
9.54
0.02
+0.21%
전일 마감가:
$9.17
열려 있는:
$9.47
하루 거래량:
2.51M
Relative Volume:
0.77
시가총액:
$1.52B
수익:
$68.56M
순이익/손실:
$-437.99M
주가수익비율:
-3.0089
EPS:
-3.1639
순현금흐름:
$-396.61M
1주 성능:
+5.54%
1개월 성능:
-0.31%
6개월 성능:
+57.36%
1년 성능:
+83.43%
1일 변동 폭
$9.20
$9.705
1주일 범위
$8.6501
$9.705
52주 변동 폭
$4.155
$10.94
비르 바이오테크 Stock (VIR) Company Profile
명칭
Vir Biotechnology Inc
전화
415-906-4324
주소
1800 OWENS STREET, SAN FRANCISCO, CA
Compare VIR vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VIR
Vir Biotechnology Inc
|
9.52 | 1.47B | 68.56M | -437.99M | -396.61M | -3.1639 |
VRTX
Vertex Pharmaceuticals Inc
|
443.92 | 109.85B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
775.53 | 80.38B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
785.07 | 47.60B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
327.25 | 42.63B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
312.19 | 33.72B | 5.36B | 287.73M | 924.18M | 2.5229 |
비르 바이오테크 Stock (VIR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-24 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2025-09-03 | 개시 | Evercore ISI | Outperform |
| 2025-08-27 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-01-29 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2023-09-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-03-06 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-02-21 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-01-27 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2022-09-14 | 개시 | SVB Leerink | Outperform |
| 2022-09-09 | 개시 | Morgan Stanley | Underweight |
| 2022-03-03 | 업그레이드 | Robert W. Baird | Underperform → Neutral |
| 2021-12-21 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2021-10-25 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2021-09-22 | 다운그레이드 | Goldman | Buy → Neutral |
| 2021-06-04 | 재개 | Robert W. Baird | Neutral |
| 2021-01-27 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2021-01-20 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-05 | 개시 | BofA Securities | Buy |
| 2020-09-14 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-09-11 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2020-08-20 | 개시 | Needham | Buy |
| 2020-03-19 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-03-13 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-02-27 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2020-02-04 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-11-14 | 개시 | Robert W. Baird | Neutral |
| 2019-11-05 | 개시 | Barclays | Overweight |
| 2019-11-05 | 개시 | Cowen | Outperform |
| 2019-11-05 | 개시 | Goldman | Buy |
| 2019-11-05 | 개시 | JP Morgan | Overweight |
모두보기
비르 바이오테크 주식(VIR)의 최신 뉴스
Vir Biotechnology, Inc. (NASDAQ:VIR) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Vir Biotechnology (NASDAQ:VIR) CEO Backer Marianne De Sells 72,559 Shares - MarketBeat
Vir Biotechnology (VIR) CEO auto-sells 72,559 shares to cover RSU tax - Stock Titan
VIR Biotechnology Inc (NASDAQ:VIR) Emerges as a High-Growth Momentum Pick - ChartMill
VIR SEC FilingsVir Biotechnology, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Exit Recap: What is the Moat Score of Vir Biotechnology Inc2026 Bull vs Bear & Weekly Momentum Stock Picks - baoquankhu1.vn
VIR (NASDAQ: VIR) Form 144 shows 72,559-share sale after vesting - Stock Titan
Evercore ISI Group Initiates Coverage of Vir Biotechnology (VIR) with Outperform Recommendation - MSN
VIR Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Market Catalysts: Is Vir Biotechnology Inc a good stock for dollar cost averaging2026 Key Highlights & AI Powered Market Trend Analysis - baoquankhu1.vn
Insider Sell: Vicki Sato Sells 22,000 Shares of Vir Biotechnology Inc (VIR) - GuruFocus
Vir Biotechnology (NASDAQ:VIR) Director Sells $199,540.00 in Stock - MarketBeat
Vir Biotechnology director Sato sells $199k in shares By Investing.com - za.investing.com
Vir Biotechnology director Sato sells $199k in shares - Investing.com
Vir Biotechnology (VIR) director sells 22,000 shares in open market - Stock Titan
VIR Earnings History & Surprises | EPS & Revenue Results | VIR BIOTECHNOLOGY INC (NASDAQ:VIR) - ChartMill
Vir Biotechnology (VIR) price target increased by 26.10% to 20.74 - MSN
Energy Moves: Is Vir Biotechnology Inc stock a smart retirement pickPortfolio Update Report & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Bull Bear: Is Vir Biotechnology Inc stock heavily shortedNew Guidance & Consistent Growth Stock Picks - baoquankhu1.vn
Investor Mood: How volatile is LGLWS stockWeekly Earnings Recap & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Why did Vir Biotechnology stock surge 60% after-hours today? - MSN
Vir Biotechnology, Inc. (VIR) Stock Forecasts - Yahoo! Finance Canada
Vanguard affiliates disaggregate holdings; VIR shows 0% ownership (VIR) - Stock Titan
These analysts boost their forecasts on Vir Biotechnology - msn.com
Vir Biotechnology (NASDAQ:VIR) CAO Sells $70,324.32 in Stock - MarketBeat
Vir Biotechnology prices $150M stock offering - MSN
Henry Schein, Vir Biotechnology, Ultra Clean Holdings and other big stocks moving higher on Tuesday - MSN
Insider Sell: Brent Sabatini Sells Shares of Vir Biotechnology I - GuruFocus
Vir Biotechnology (VIR) accounting chief sells 7,711 shares under plan - Stock Titan
Vir Biotechnology (VIR) CFO restructures 5,000 shares via family trust transfer - Stock Titan
Insider sales at VIR (NASDAQ: VIR) include multiple February 2026 transactions - Stock Titan
Valuation Update: Is Vir Biotechnology Inc stock influenced by commodity prices2026 Sector Review & Verified Stock Trade Ideas - baoquankhu1.vn
Hudson Bay Capital Management LP Grows Position in Vir Biotechnology, Inc. $VIR - MarketBeat
Guidance Update: What is the Moat Score of Vir Biotechnology IncPortfolio Value Report & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Vir Biotechnology, Inc. (NASDAQ:VIR) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
비르 바이오테크 (VIR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.51%
1.75%
자본화:
|
볼륨(24시간):